← Back to Search

Ovarian Tissue Cryopreservation for Premature Ovarian Failure

N/A

Recruiting

Led By Glenn Schattman, MD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Treatment plan that will likely result in premature menopause or premature ovarian failure. This includes patients receiving: Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy, Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients

Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos

Must not have

Patients who have not received medical clearance from their physicians to undergo surgery

Patients already experiencing menopause

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months to a year post surgery, hormone testing will be performed to test ovarian function.

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way to freeze and thaw ovarian tissue so that a woman with premature ovarian failure can have a baby that is genetically related to her.

Who is the study for?

This trial is for premenopausal females aged 0-45 who may lose their ovarian function due to cancer treatments or need their ovaries removed. It's also for those who can't or don't want to freeze eggs or embryos but are medically cleared for surgery.

What is being tested?

The study tests the effectiveness of freezing and thawing ovarian tissue, as well as maturing immature eggs in a lab setting. This could help women at risk of early ovarian failure have genetically related children in the future.

What are the potential side effects?

Potential side effects include those associated with surgical removal of ovaries and high dose chemotherapy, such as pain, infection risks from surgery, nausea, hair loss, fatigue from chemo, and fertility-related hormonal changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My treatment may cause early menopause due to radiation, chemotherapy, or surgery.

Select...

I am not planning to freeze my eggs or embryos for future use.

Select...

I am a woman aged 0-45 and have not gone through menopause.

Select...

I am cleared by a doctor to have surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I haven't been cleared by my doctor for surgery.

Select...

I have gone through menopause.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months to a year post surgery, hormone testing will be performed to test ovarian function.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months to a year post surgery, hormone testing will be performed to test ovarian function.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months to a year post surgery, hormone testing will be performed to test ovarian function. for reporting.